Mark Levick

Mark Levick

No open positions remaining
62 year
Health Technology
Consumer Services
Commercial Services

Profile

Mark Levick served as Global Head-Development at Sandoz Biopharmaceuticals from 2016 to 2019.
Dr. Levick was Chief Executive Officer at Alvotech from 2019 to 2023.
Dr. Levick was Chief Executive Officer & Director at InterAx Biotech AG from 2023 to 2025.
Dr. Levick was Chief Executive Officer at Alvotech hf.
Dr. Levick was Global Head at Novartis AG.
Dr. Levick earned a doctorate from the University of Cambridge and completed undergraduate studies at The University of Newcastle.

Former positions of Mark Levick

CompaniesPositionEnd
Chief Executive Officer 17/10/2025
ALVOTECH Chief Executive Officer 01/01/2023
Sandoz Biopharmaceuticals
Corporate Officer/Principal 01/01/2019
NOVARTIS AG Corporate Officer/Principal 01/07/2016
Chief Executive Officer -
See the detail of Mark Levick's experience

Training of Mark Levick

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

18

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Sandoz Biopharmaceuticals